Published by Drug Driving Solicitors, specialist UK solicitors defending drivers facing drug driving charges.
Cannabis and driving law can create a difficult next-day problem. A person may have used cannabis the previous evening, slept normally and woken up feeling completely sober, yet still have THC in their blood at a concentration that creates legal risk. Unlike a simple assessment of whether someone appears intoxicated, the specified-limit offence focuses on the measured concentration of the drug.
Under Section 5A of the Road Traffic Act 1988, it is an offence to drive, attempt to drive or be in charge of a vehicle with a specified controlled drug above the prescribed limit. For THC, the cannabis limit in England and Wales is 2 micrograms per litre of blood. The government describes cannabis as belonging to its low-limit, "zero tolerance" group, with the threshold intentionally set above absolute zero to reduce the risk of accidental exposure being caught by the offence. Understanding why THC can remain relevant the following day helps explain why simply waiting until the obvious effects have disappeared is not always enough.
Smoking or vaping cannabis delivers THC through the lungs, so concentrations rise rapidly and the effects are usually noticed relatively quickly. Edibles follow a very different route. THC must first pass through the digestive system and liver, meaning absorption is slower and considerably more variable from one person and product to another.
Research into oral THC has found that peak concentrations generally occur later than with inhaled cannabis. Reviews have also identified substantial variation between oral formulations, including baked products, oils, tablets and capsules. This makes the timeline following an edible less predictable than simply applying the same waiting period someone might associate with smoking or vaping.
With inhaled cannabis, blood THC can peak within minutes before falling relatively quickly. Oral cannabis may take hours to reach its peak. In controlled studies, the subjective effects of edibles have commonly peaked around 1.5 to 3 hours after ingestion and persisted for several hours afterwards.
That difference becomes important when cannabis is consumed late in the evening. Someone who takes an edible shortly before bed cannot safely assume that the clock started running from the moment it was swallowed in the same way it might after smoking. The delayed absorption and longer pharmacological timeline can push relevant THC exposure further into the night and, depending on the dose and individual, potentially closer to the following morning.
People naturally judge cannabis by how they feel. Once the altered perception, relaxation, slowed reactions or other noticeable effects have disappeared, it is easy to conclude that the cannabis has left the body as well. Those are not necessarily the same thing.
Subjective intoxication is influenced by tolerance, dose, route of administration and individual response. Blood THC is a laboratory measurement. A person can therefore feel considerably different at two points in time without being able to tell from sensation alone whether their blood concentration has crossed a particular legal threshold.
This distinction is particularly important under the specified-limit offence. The prosecution does not have to establish that the driver felt high or was obviously impaired in order to prove a Section 5A offence. The legislation concerns whether the concentration of the specified controlled drug exceeded its prescribed limit. The Crown Prosecution Service describes Section 5A as a strict-liability offence designed to avoid the need to prove impairment.
GOV.UK likewise states that it can be illegal to drive with certain drugs above their specified blood levels even where they have not affected the person's driving. Feeling alert, coordinated and completely normal the next morning is therefore not equivalent to knowing that the THC concentration in your blood is below the legal limit.
THC is highly lipophilic, meaning it has a strong affinity for fatty tissues. After entering the bloodstream, it distributes into tissues throughout the body rather than remaining only in the blood until it is steadily eliminated. Research into cannabinoid pharmacokinetics describes THC as being stored in body fat and later released gradually back into circulation.
This is one reason comparisons with alcohol can be misleading. People are accustomed to hearing rough estimates about how quickly the body processes alcohol. THC has a much more complicated distribution and redistribution pattern, so there is no equally simple "one unit per hour" style calculation that can tell a cannabis user when their blood concentration will fall below 2 micrograms per litre.
Blood THC concentrations can fall sharply after cannabis is inhaled, particularly after the initial peak. That rapid early decline does not mean every trace of THC has immediately left the body. Some of the compound has already moved into tissues, creating a longer elimination phase afterwards.
Studies of cannabinoid pharmacokinetics have specifically linked prolonged THC elimination in frequent users to storage and subsequent release from body fat. For a driver, the important point is not that stored THC automatically means they will be above the driving limit the following day. It means that cannabis clearance does not follow a simple countdown, and residual concentrations can be more persistent than the disappearance of the obvious high might suggest.
Someone who uses cannabis once every few months presents a different pharmacokinetic picture from someone who uses it every evening. With repeated exposure, THC can accumulate in tissues, meaning a frequent user may begin each new episode of cannabis use before all residual THC from previous use has disappeared.
Research involving frequent cannabis users has demonstrated measurable THC after extended periods of abstinence. Studies of chronic use have also shown that THC can persist considerably longer in frequent users because of accumulation and slow release from fatty tissues.
This matters when someone thinks only about the cannabis used immediately before driving. A driver may say, quite accurately, that they stopped using cannabis at 9 pm the previous evening. For a regular user, however, their blood concentration the next morning may reflect not only that single episode but also the residual effect of a repeated pattern of consumption.
That does not mean every regular cannabis user remains over the legal limit for days, nor does detection automatically prove impairment. Concentrations vary considerably between individuals. It does mean that a waiting period that appeared sufficient for an occasional user cannot safely be assumed to produce the same blood result in someone who consumes cannabis frequently or heavily.
In England and Wales, the specified blood limit for delta-9-tetrahydrocannabinol is 2 micrograms per litre. Cannabis is among the controlled drugs for which the government adopted a low-limit approach commonly described as "zero tolerance", although the threshold was placed above literal zero partly to avoid problems caused by accidental exposure.
That distinction is important. The limit should not be interpreted as the concentration at which a person suddenly becomes seriously impaired. Nor should a driver assume that being under the level at which they personally notice cannabis effects means that they must also be under the statutory threshold.
Section 5A separates the specified-limit offence from the older offence of driving while unfit through drugs. For a Section 5A prosecution, the central issue is the concentration of the specified drug rather than whether prosecutors can prove that the person's driving ability was visibly affected.
This is why the morning after can create an unexpected risk. A relatively low residual THC concentration may have little relationship with how intoxicated a person believes themselves to be, yet the statutory threshold itself is also low. Once a blood result is alleged to exceed that threshold, the legal question is very different from simply asking whether the driver looked or felt heavily under the influence.
There is no single human metabolism. Two people can consume the same cannabis product at the same time and produce different concentration curves because absorption, distribution and metabolism vary. Body composition, metabolic differences, eating patterns, dose, product strength and frequency of previous cannabis use can all contribute to the resulting pharmacokinetic picture.
Body fat is particularly relevant because THC is lipophilic and can distribute into fatty tissue. At the same time, body weight alone cannot reliably predict how quickly a particular person will fall below the legal driving limit. The interaction between dose, physiology, tolerance, consumption history and route of administration is too complicated for a simple calculation based on kilograms or body size.
Hydration status is sometimes discussed alongside metabolism and drug testing, but drinking large quantities of water should not be treated as a method of rapidly removing THC from the bloodstream. Fluid intake may affect the concentration of some substances in urine, but it cannot reliably override the way THC has already been absorbed, metabolised and distributed through body tissues.
The same caution applies to exercise, coffee, food, showers or sleep. Feeling fresher afterwards does not provide a measurement of blood THC. Individual physiological differences help explain why one person may produce a different result from another, but they do not provide a dependable home method for predicting whether a driver's concentration has fallen below 2 micrograms per litre.
The central difficulty with cannabis is that the disappearance of the high, the reduction of impairment and the fall in blood THC are related processes, but they are not interchangeable measurements. Low statutory limits, tissue storage, repeated use, individual physiology and different methods of consumption can all complicate the next-day picture. For drivers, this means that feeling normal after a night's sleep cannot by itself establish that a blood THC concentration is below the applicable legal threshold.
Yes. Section 5A is a specified-limit offence, so prosecutors do not have to prove careless, dangerous or visibly impaired driving if they are relying on an evidential blood concentration above the prescribed limit. Police powers to require preliminary drug testing are subject to statutory conditions, however. A roadside drug test is not available simply because an officer has stopped a vehicle for no further reason. Circumstances such as reasonable suspicion of drugs, certain road traffic offences or involvement in an accident can provide grounds for preliminary testing.
There is no universal detection period. After a single episode of use, blood THC can decline substantially within hours, particularly following inhalation, but the duration depends on the dose, testing sensitivity, route of administration and the person's history of cannabis use. Frequent users may retain measurable THC substantially longer because repeated exposure can lead to accumulation and slow release from tissues. Importantly, being "detectable" is not the same thing as being above the statutory driving limit.
No. A roadside saliva test is a preliminary screening tool rather than the evidential measurement used to establish the statutory blood concentration. Government guidance explains that after a positive oral-fluid screen, a blood specimen can be required for evidential analysis. The blood analysis, together with the circumstances and procedural evidence, is what matters to a Section 5A prosecution. Depending on the case, issues concerning the testing process, continuity of evidence, analytical result or legal procedure may require examination, which is why obtaining specialist advice early can be important.
No official waiting period can guarantee that every person's blood THC concentration will be below the specified limit. Cannabis pharmacokinetics vary according to frequency of use, dose, individual physiology and the method of consumption, while oral products can have particularly delayed and variable absorption. This makes simple hour-by-hour rules unreliable. A laboratory blood analysis is the method used to determine the actual concentration at a particular point in time.
Where a specified controlled drug has been lawfully prescribed or supplied for medical or dental purposes and has been taken in accordance with the relevant directions, Section 5A provides a statutory medical defence, subject to its legal requirements. The defence does not permit someone to drive while impaired, and failing to follow the relevant medical directions can prevent the defence from applying. Recreational cannabis being lawful in the country where it was consumed does not itself provide an automatic defence to driving over the applicable limit in Great Britain, and neither does informal self-medication or unknowingly consuming a CBD product containing THC.
Seek specialist legal advice as early as possible. A next-day cannabis allegation can involve more than the simple fact that cannabis was used. The timing and method of consumption, frequency of previous use, circumstances leading to the test, evidential blood procedure, laboratory result and any potentially applicable defence may all need to be considered before conclusions are drawn about the strength of the prosecution case.
Drug Driving Solicitors focus on defending motorists accused of drug driving offences across the UK. If you have been charged following a cannabis blood result above the applicable limit, contact Drug Driving Solicitors for a free and confidential initial consultation about your case.